Revvity, Inc. (NYSE:RVTY) Shares Sold by Swiss National Bank

Swiss National Bank reduced its stake in shares of Revvity, Inc. (NYSE:RVTY) by 4.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 348,400 shares of the company’s stock after selling 17,300 shares during the period. Swiss National Bank owned approximately 0.29% of Revvity worth $38,885,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in RVTY. Sumitomo Mitsui Trust Group Inc. lifted its position in Revvity by 3.3% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 299,723 shares of the company’s stock valued at $38,290,000 after purchasing an additional 9,473 shares during the period. Victory Capital Management Inc. lifted its position in Revvity by 4.5% during the third quarter. Victory Capital Management Inc. now owns 59,860 shares of the company’s stock valued at $7,647,000 after purchasing an additional 2,582 shares during the period. Metis Global Partners LLC lifted its position in Revvity by 6.5% during the third quarter. Metis Global Partners LLC now owns 7,825 shares of the company’s stock valued at $1,000,000 after purchasing an additional 481 shares during the period. CIBC Asset Management Inc lifted its position in Revvity by 8.2% during the third quarter. CIBC Asset Management Inc now owns 17,993 shares of the company’s stock valued at $2,299,000 after purchasing an additional 1,368 shares during the period. Finally, Empirical Finance LLC lifted its position in Revvity by 2.0% during the third quarter. Empirical Finance LLC now owns 4,237 shares of the company’s stock valued at $541,000 after purchasing an additional 85 shares during the period. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Revvity

In related news, insider Tajinder S. Vohra sold 5,492 shares of the company’s stock in a transaction dated Tuesday, January 7th. The shares were sold at an average price of $116.81, for a total transaction of $641,520.52. Following the completion of the sale, the insider now owns 19,652 shares of the company’s stock, valued at approximately $2,295,550.12. This represents a 21.84 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Joel S. Goldberg sold 15,170 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the sale, the insider now directly owns 33,400 shares of the company’s stock, valued at approximately $4,232,782. This represents a 31.23 % decrease in their position. The disclosure for this sale can be found here. 0.60% of the stock is owned by corporate insiders.

Revvity Stock Up 1.6 %

RVTY stock opened at $112.13 on Monday. The stock has a market capitalization of $13.47 billion, a P/E ratio of 50.74, a P/E/G ratio of 3.82 and a beta of 1.06. The firm has a 50-day simple moving average of $117.01 and a 200-day simple moving average of $117.93. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41. Revvity, Inc. has a 52 week low of $97.32 and a 52 week high of $129.50.

Revvity (NYSE:RVTY) last released its earnings results on Friday, January 31st. The company reported $1.42 EPS for the quarter, topping analysts’ consensus estimates of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same quarter in the previous year, the company earned $1.25 earnings per share. Equities analysts forecast that Revvity, Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be paid a dividend of $0.07 per share. The ex-dividend date is Thursday, April 17th. This represents a $0.28 annualized dividend and a yield of 0.25%. Revvity’s dividend payout ratio is presently 12.67%.

Analysts Set New Price Targets

RVTY has been the subject of a number of research reports. Raymond James restated an “outperform” rating and set a $145.00 target price (up from $140.00) on shares of Revvity in a research report on Monday, February 3rd. KeyCorp upped their price objective on shares of Revvity from $132.00 to $145.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. Sanford C. Bernstein downgraded shares of Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price objective for the company. in a research report on Friday, January 10th. Bank of America upgraded shares of Revvity from a “neutral” rating to a “buy” rating and set a $138.00 price objective for the company in a research report on Friday, December 13th. Finally, Barclays upped their price objective on shares of Revvity from $135.00 to $140.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. Four analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $136.25.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.